Calcutta HC: Award May Be Set Aside if Tribunal Rewrites Contract or Ignores Key Clauses  ||  Delhi HC Suspends Kuldeep Singh Sengar’s Life Term, Holding Section 5(C) of POCSO Not Made Out  ||  Calcutta High Court: Arbitration Clause in an Expired Lease Cannot be Invoked For a Fresh Lease  ||  Delhi High Court: 120-Day Timeline under Section 132B Of Income Tax Act is Not Mandatory  ||  NCLAT Reaffirms That Borrower's Debt Acknowledgment Also Extends Limitation Period for Guarantors  ||  NCLAT: Oppression & Mismanagement Petition Cannot Be Filed Without Company Membership on Filing Date  ||  Supreme Court Quashes Rajasthan Village Renaming, Says Government Must Follow its Own Policy  ||  NCLAT: NCLT Can Order Forensic Audit on its Own, No Separate Application Required  ||  NCLAT Reiterates That IBC Cannot be Invoked as a Recovery Tool for Contractual Disputes  ||  Delhi HC: DRI or Central Revenues Control Lab Presence in Delhi Alone Does Not Confer Jurisdiction    

Cabinet approves MoU between India and Uzbekistan on cooperation for establishment of Uzbek-Indian Free Pharmaceutical Zone in the Andijan region of Uzbekistan- (Press Information Bureau) (26 Sep 2018)

MANU/PIBU/1352/2018

Law of Medicine

The Union Cabinet chaired by Prime Minister Shri Narendra Modi has approved the Memorandum of Understanding (MoU) between India and Uzbekistan for establishment of the Uzbek-Indian Free Pharmaceutical Zone in the Andijan Region of Uzbekistan. The MoU will be signed during the visit of President of Uzbekistan to India on 1st October 2018.

In view of the importance of the growth of the pharmaceuticals and biopharmaceutical industry in both countries and the importance of mutual cooperation in trade, industry and production in the pharmaceutical and biopharmaceutical sectors, both the countries have been trying to establish a formal mechanism of bilateral cooperation. The MoU will create an enabling framework of cooperation for setting up an Uzbek-Indian Free Pharmaceuticals Zone in Andijan region of Uzbekistan. It will also facilitate Indian pharmaceutical and biopharmaceutical companies to invest in and establish production facilities in the Uzbek-Indian Free Pharma Zone of Andijan for manufacture of Pharmaceutical Products.

Tags : MOU   APPROVAL   PHARMACEUTICAL ZONE  

Share :        

Disclaimer | Copyright 2025 - All Rights Reserved